The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management
Abstract
Objective: To review recent advances in the epidemiology, pathobiology, and management of weight gain and obesity in patients with schizophrenia and to evaluate the extent to which they should influence guidelines for clinical practice. Method: A Medline literature search was performed to identify clinical and experimental studies published in 2005–2014 decade. Results: Weight gain and obesity increase the risk of adult‐onset diabetes mellitus and cardiovascular disorders, non‐adherence with pharmacological interventions, quality of life, and psychiatric readmissions. The etiology includes adverse effects of antipsychotics, pretreatment/premorbid genetic vulnerabilities, psychosocial and socioeconomic risk factors, and unhealthy lifestyle. Patients with schizophrenia have higher intake of calories in the form of high‐density food and lower energy expenditure. The inverse relationship between baseline body mass index and antipsychotic‐induced weight gain is probably due to previous antipsychotic exposure. In experimental models, the second‐generation antipsychotic olanzapine increased the orexigenic stimulation of hypothalamic structures responsible for energy homeostasis. Conclusion: The management of weight gain and obesity in patients with schizophrenia centers on behavioural interventions using caloric intake reduction, dietary restructuring, and moderate‐intensity physical activity. The decision to switch antipsychotics to lower‐liability medications should be individualized, and metformin may be considered for adjunctive therapy, given its favorable risk‐benefit profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735
DONNELLY, J. E., BLAIR, S. N., JAKICIC, J. M., MANORE, M. M., RANKIN, J. W., & SMITH, B. K. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181949333 · Cited by 2,658
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Self-citationSecond-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
The Look AHEAD Research Group (2007) · Diabetes Care · doi:10.2337/dc07-0048 · Cited by 1,522
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Thornicroft, G., Brohan, E., Rose, D., Sartorius, N., & Leese, M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61817-6 · Cited by 1,189
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088
Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr148 · Cited by 1,082
Self-citationCorrell, C. U. (2009) · JAMA · doi:10.1001/jama.2009.1549 · Cited by 1,050
Self-citationMueser, K. T., & McGurk, S. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16458-1 · Cited by 876
DE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00036.x · Cited by 870
Self-citationAjala, O., English, P., & Pinkney, J. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.042457 · Cited by 821 · cited 1×
“The macronutrient composition is less important than the caloric restriction (79), but low carbohydrate and Mediterranean diets led to greater weight loss than high-protein or low-glycemic index regimens (80).”
BackgroundKroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300027 · Cited by 801
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633
A Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness
Daumit, G. L., Dickerson, F. B., Wang, N.-Y., Dalcin, A., Jerome, G. J., Anderson, C. A. M., Young, D. R., Frick, K. D., Yu, A., Gennusa, J. V., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214530 · Cited by 523
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
Bak, M., Fransen, A., Janssen, J., van Os, J., & Drukker, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094112 · Cited by 490
The dietary pattern of patients with schizophrenia: A systematic review
Dipasquale, S., Pariante, C. M., Dazzan, P., Aguglia, E., McGuire, P., & Mondelli, V. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.005 · Cited by 394
Kim, S. F., Huang, A. S., Snowman, A. M., Teuscher, C., & Snyder, S. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611417104 · Cited by 394
De Hert, M., Dobbelaere, M., Sheridan, E. M., Cohen, D., & Correll, C. U. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.09.011 · Cited by 362
Self-citationAntipsychotic drugs and obesity
Correll, C. U., Lencz, T., & Malhotra, A. K. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.010 · Cited by 307
Self-citationSystematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
Foley, D. L., & Morley, K. I. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2 · Cited by 287
Meyer, J. M., Davis, V. G., Goff, D. C., McEvoy, J. P., Nasrallah, H. A., Davis, S. M., Rosenheck, R. A., Daumit, G. L., Hsiao, J., Swartz, M. S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.487 · Cited by 286
Correll, C. U. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71701-6 · Cited by 273
Self-citationRummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Kissling, W., Davis, J. M., & Leucht, S. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq042 · Cited by 272
Álvarez-Jiménez, M., González-Blanch, C., Crespo-Facorro, B., Hetrick, S., Rodríguez-Sánchez, J. M., Pérez-Iglesias, R., & Vázquez-Barquero, J. L. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00002 · Cited by 264
Correll, C. U., Sheridan, E. M., & DelBello, M. P. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00798.x · Cited by 255
Self-citationMarital and Labor Market Status in the Long Run in Schizophrenia
Agerbo, E., Byrne, M., Eaton, W. W., & Mortensen, P. B. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.28 · Cited by 254
Maayan, L., & Correll, C. U. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0015 · Cited by 252
Self-citationGothelf, D., Falk, B., Singer, P., Kairi, M., Phillip, M., Zigel, L., Poraz, I., Frishman, S., Constantini, N., Zalsman, G., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1055 · Cited by 246
Maayan, L., Vakhrusheva, J., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.21 · Cited by 230
Self-citationGreen, C. A., Yarborough, B. J. H., Leo, M. C., Yarborough, M. T., Stumbo, S. P., Janoff, S. L., Perrin, N. A., Nichols, G. A., & Stevens, V. J. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14020173 · Cited by 210
Fraguas, D., Correll, C. U., Merchán-Naranjo, J., Rapado-Castro, M., Parellada, M., Moreno, C., & Arango, C. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.07.002 · Cited by 209
Self-citationAntipsychotic treatment and mortality in schizophrenia.
Torniainen, M., Mittendorfer-Rutz, E., Tanskanen, A., Bjorkenstam, C., Suvisaari, J., Alexanderson, K., & Tiihonen, J. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu164 · Cited by 208
Safety and tolerability of antipsychotic polypharmacy
Gallego, J. A., Nielsen, J., De Hert, M., Kane, J. M., & Correll, C. U. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.683523 · Cited by 205
Self-citationMizuno, Y., Suzuki, T., Nakagawa, A., Yoshida, K., Mimura, M., Fleischhacker, W. W., & Uchida, H. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu030 · Cited by 202
Stroup, T. S., McEvoy, J. P., Ring, K. D., Hamer, R. H., LaVange, L. M., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Nussbaum, A. M., Lieberman, J. A., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111609 · Cited by 193
Weight effects associated with antipsychotics: A comprehensive database analysis
Parsons, B., Allison, D. B., Loebel, A., Williams, K., Giller, E., Romano, S., & Siu, C. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.025 · Cited by 191
Malhotra, A. K. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.191 · Cited by 185
Correll, C. U., Penzner, J. B., Parikh, U. H., Mughal, T., Javed, T., Carbon, M., & Malhotra, A. K. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2005.08.007 · Cited by 184
Self-citationCaemmerer, J., Correll, C. U., & Maayan, L. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.017 · Cited by 182
Kinon, B. J., Kaiser, C. J., Ahmed, S., Rotelli, M. D., & Kollack-Walker, S. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000161501.65890.22 · Cited by 165
De Hert, M., Yu, W., Detraux, J., Sweers, K., van Winkel, R., & Correll, C. U. (2012) · CNS Drugs · doi:10.2165/11634500-000000000-00000 · Cited by 161
Self-citationGraham, K. A., Perkins, D. O., Edwards, L. J., Barrier, R. C., Lieberman, J. A., & Harp, J. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.118 · Cited by 151
Coccurello, R., & Moles, A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.008 · Cited by 147
Deng, C., Weston–Green, K., & Huang, X. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.009 · Cited by 145
Strassnig, M., Miewald, J. M., Keshavan, M. S., & Ganguli, R. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.02.024 · Cited by 135
Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder
Maina, G., Salvi, V., Vitalucci, A., D’Ambrosio, V., & Bogetto, F. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.12.233 · Cited by 135
Management of antipsychotic-related weight gain
Maayan, L. A., & Correll, C. U. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.85 · Cited by 133
Self-citationNewcomer, J. W., Campos, J. A. D. O., Marcus, R. N., Breder, C. D., Berman, R., Kerselaers, W., L'Italien, G. J., Nys, M., Carson, W. H., & McQuade, R. D. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0702 · Cited by 132
Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics
Hasnain, M., Fredrickson, S. K., Vieweg, W. V. R., & Pandurangi, A. K. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0112-8 · Cited by 121
Citrome, L., Holt, R. I. G., Walker, D. J., & Hoffmann, V. P. (2011) · Clinical Drug Investigation · doi:10.2165/11589060-000000000-00000 · Cited by 118
Weight gain in antipsychotic-naive patients: a review and meta-analysis
Tarricone, I., Gozzi, B. F., Serretti, A., Grieco, D., & Berardi, D. (2009) · Psychological Medicine · doi:10.1017/s0033291709990407 · Cited by 114
Mukundan, A., Faulkner, G., Cohn, T. A., & Remington, G. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006629.pub2 · Cited by 110
Weston–Green, K., Huang, X., & Deng, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033548 · Cited by 94
He, M. X., Zhang, Q., Deng, C., Wang, H., Lian, J., & Huang, X. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.018 · Cited by 93
The association between weight change and symptom reduction in the CATIE schizophrenia trial
Hermes, E. D. A., Nasrallah, H. A., Davis, V. G., Meyer, J. M., McEvoy, J. P., GOFF, D. C., Thomas, S., Stroup, T. S., Swartz, M. S., Lieberman, J. A., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.01.022 · Cited by 88
Song, X., Fan, X., Song, X., Zhang, J., Zhang, W., Li, X., Gao, J., Harrington, A., Ziedonis, D. M., & Lv, L. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.044 · Cited by 82
Long-Term Changes in Weight and Plasma Lipids during Maintenance Treatment with Ziprasidone
Weiden, P. J., Newcomer, J. W., Loebel, A. D., Yang, R., & Lebovitz, H. E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301482 · Cited by 77
Poyurovsky, M., Fuchs, C., Pashinian, A., Levi, A., Weizman, R., & Weizman, A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2935-2 · Cited by 74
Lian, J., Huang, X., Pai, N. B., & Deng, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104160 · Cited by 69
Bai, Y. M., Chen, T. T., Yang, W., Chi, Y.-C., Lin, C.-C., Liou, Y., Wang, Y., Su, T., Chou, P., & Chen, J.-Y. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.014 · Cited by 67
Markers of inflammation in schizophrenia: association vs. causation
Manu, P., Correll, C. U., Wampers, M., Mitchell, A. J., Probst, M., Vancampfort, D., & De Hert, M. (2014) · World Psychiatry · doi:10.1002/wps.20117 · Cited by 59
Self-citationWeight Change From 3-Year Observational Data
Bushe, C., Slooff, C. J., Haddad, P. M., & Karagianis, J. L. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07246 · Cited by 58
Emerging drugs for schizophrenia: an update
Köster, L.-S., Carbon, M., & Correll, C. U. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.958148 · Cited by 55
Self-citationZhang, Q., He, M. X., Deng, C., Wang, H., Lian, J., & Huang, X. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001697 · Cited by 54
Pharmacological Management of Obesity in Pediatric Patients
Boland, C. L., Harris, J. B., & Harris, K. B. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014557859 · Cited by 54
Tiwari, A. K., Brandl, E. J., Weber, C. I., Likhodi, O., Zai, C. C. H., Hahn, M., Lieberman, J. A., Meltzer, H. Y., Kennedy, J. L., & Müller, D. J. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31827d145a · Cited by 53
Allison, D. B., Loebel, A. D., Lombardo, I., Romano, S. J., & SIU, C. O. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.007 · Cited by 51
García-Manzanares, N., Monseny, R., Ortega, L., Montalvo, I., Franch, J., Gutiérrez‐Zotes, A., Reynolds, R. M., Walker, B. R., Vilella, E., & Labad, J. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.023 · Cited by 51
Coccurello, R., Caprioli, A., Ghirardi, O., Conti, R., Ciani, B., Daniele, S., Bartolomucci, A., & Moles, A. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0368-5 · Cited by 49
Determinants of resting energy expenditure in obese and non-obese children and adolescents
Rodríguez, G., Moreno, L. A., Sarría, A., Pineda, I., Fleta, J., Pérez-González, J. M., & Bueno, M. (2002) · Journal of Physiology and Biochemistry · doi:10.1007/bf03179833 · Cited by 48
Smith, G. C., Vickers, M. H., & Shepherd, P. R. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.576681 · Cited by 48
Bushe, C., Slooff, C. J., Haddad, P. M., & Karagianis, J. L. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112473789 · Cited by 48
Kryzhanovskaya, L. A., Xu, W., Millen, B. A., Acharya, N. V., Jen, K. Y., & Osuntokun, O. O. (2012) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0020 · Cited by 48
Sharpe, J.-K., Byrne, N. M., STEDMAN, T. J., & Hills, A. P. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2005.01.005 · Cited by 47
Wampers, M., Hanssens, L., van Winkel, R., Heald, A. H., Collette, J., Peuskens, J., Reginster, J., Scheen, A. J., & Binder, M. D. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.010 · Cited by 46
Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission
Manu, P., Khan, S., Radhakrishnan, R., Russ, M. J., Kane, J. M., & Correll, C. U. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08795 · Cited by 45
Self-citationCorrell, C. U., Sikich, L., Reeves, G. M., & Riddle, M. A. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13060771 · Cited by 40
Self-citationHanssens, L. S., VANWINKEL, R., Wampers, M., VANEYCK, D., Scheen, A. J., Reginster, J., Collette, J., Peuskens, J., & DEHERT, M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.008 · Cited by 40
Self-citationPérez‐Iglesias, R., de la Foz, V. O., Martínez‐García, O., Amado, J., García‐Unzueta, M. T., Ayesa‐Arriola, R., Suárez‐Pinilla, P., Tabarés‐Seisdedos, R., & Crespo‐Facorro, B. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.045 · Cited by 39
Chen, Y., Bobo, W. V., Watts, K., Jayathilake, K., Tang, T., & Meltzer, H. Y. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111430748 · Cited by 37
Cuerda, C., Merchán‐Naranjo, J., Velasco, C., Gutiérrez, A., Leiva, M., de Castro, M. J., Parellada, M., Giráldez, M., Lesmes, I. B., Camblor, M., et al. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.03.007 · Cited by 36
Pathophysiology, epidemiology, and assessment of obesity in adults.
SKOLNIK, N., & Ryan, D. H. (2014) · PubMed · Cited by 34
Moons, T., Claes, S. J., Martens, G. J. M., Peuskens, J., van Loo, K. M. J., van Schijndel, J. E., Binder, M. D., & van Winkel, R. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.10.008 · Cited by 33
Nunes, D., Eskinazi, B., Rockett, F. C., Delgado, V. B., & Perry, I. D. S. (2013) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2013.07.001 · Cited by 31
de Souza, R. P., Tiwari, A. K., Chowdhury, N. I., Ceddia, R. B., Lieberman, J. A., Meltzer, H. Y., Kennedy, J. L., & Müller, D. J. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.01.010 · Cited by 29
Millen, B. A., Campbell, G. M., & Beasley, C. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110370505 · Cited by 26
Wang, Y., Bai, Y., Chen, J., Lin, C., Lai, I., & Liou, Y. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1122 · Cited by 26
Treatment decisions in major mental illness: weighing the outcomes.
Vreeland, B. (2007) · PubMed · Cited by 25
Serum leptin and its relationship with psychopathology in schizophrenia
Nurjono, M., Neelamekam, S., & Lee, J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.08.017 · Cited by 24
Ehrlich, S., Leopold, K., Merle, J. V., Theophil, I., Haag, W., Lautenschlager, M. M., & Schaefer, M. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318270e5c5 · Cited by 19
Nunes, D., Eskinazi, B., Rockett, F. C., Delgado, V. B., & Perry, I. D. S. (2014) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2014.01.001 · Cited by 18
Low‐fat oxidation may be a factor in obesity among men with schizophrenia
Sharpe, J.-K., STEDMAN, T. J., Byrne, N. M., & Hills, A. P. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01342.x · Cited by 13
Huang, H.-H., Wang, Y., Wu, C., Hong, C., Bai, Y., Tsai, S., & Liou, Y. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.046 · Cited by 12
The pharmacological and surgical management of adults with obesity.
Ryan, D. H. (2014) · PubMed · Cited by 7
Tips for communicating with overweight and obese patients.
Campos, C. (2014) · PubMed · Cited by 6
Cited by
Pillinger, T., McCutcheon, R. A., Vano, L., Mizuno, Y., Arumuham, A., Hindley, G., Beck, K., Natesan, S., Efthimiou, O., Cipriani, A., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30416-x · Cited by 1,090
Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438
Self-citationInternational trends in clozapine use: a study in 17 countries
Bachmann, C. J., Aagaard, L., Bernardo, M., Brandt, L., Cartabia, M., Clavenna, A., Coma Fusté, A., Furu, K., Garuoliené, K., Hoffmann, F., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12742 · Cited by 314
Cooper, S. J., Reynolds, G. P., order):, W. E. C.-A. (. A., Barnes, T., England, E., Haddad, P., Heald, A., Holt, R., Lingford-Hughes, A., Osborn, D., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645254 · Cited by 292
Carbon, M., Kane, J. M., Leucht, S., & Correll, C. U. (2018) · World Psychiatry · doi:10.1002/wps.20579 · Cited by 214
Metadata
- Authors
- Manu, P., Dima, L., Shulman, M., Vancampfort, D., De Hert, M., & Correll, C. U.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2015-05-27
- Volume
- 132
- Issue
- 2
- Pages
- 97-108
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W1596339956
- Cited by
- 285
- References
- 102
- FWCI
- 19.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.